Here are some interesting facts about shorting in RGRX now. It goes to show that the MM (nite) really was behind the slam and trade down to RGRX looking at perhaps bankruptcy....down to a trade of 4 cents. NITE's shorting was relentless, as all us long timers posted the daily FINRA stats, yet somehow the SEC published the short interest in RGRX was almost zero.
The proof is in the numbers. The minute that NITE halted the short and scam down game in RGRX, RGRX rises. And RGRX is holding well. Sure, there has been some upbeat news..but in the past, NITE would short heck into the news. No longer. NITE is not playing the short scam down much anymore...but the still use bonkers donkers to do their dirty work.
SO. Here are short facts. In the last 21 trading days, RGRX has traded 1,390,127 shares. In those same 21 days, a mere 56,133 shares were shorted. It wasn't long ago when NITE was shorting 50%, 60% and on one day a few months ago..100% of the daily RGRX volume.
This really does show that a single MM can indeed manipulate a stock as they see fit. Clearly NITE did it for 2-3 years in RGRX. But now NITE is running scared and chicken. They might still be short some....but they aren't shorting much more. They can't control it like they have before.....buyers seem around now. But they still keep bonkers donkers on the payroll.
Either you are a short trying to spread lies.....or you are an ignorant long, spewing even more incorrect falsehoods. You really should do the simple stuff before you invest. Especially with a stock that is almost $4,000 a share.
you state that I am wrong and it is impossible for Bresky to own over 900,000 share of SEB, when only 1.17 million shares exist?? Duhh.....read any SEC filings lately? You are correct. i was wrong. Bresky does not own 900,000 shares.he actually owns about 907,754 shares!!! or 77.7% of SEB. You see, had you lifted a finger, you would see that the 907,000 shares of SEB is in TRUST for the family..and guess WHO controls the TRUSTS. Ever hear of Steven Bresky? The CEO of SEB?? he controls a little doozie called Seaboard Flour LLC......see what they own??
" Steven J. Bresky(1) 907,754.24 77.6%
c/o Seaboard Flour LLC
1320 Centre Street, Suite 200
Newton Center, MA 02459
interesting on Shoe. But a few years ago, Shire bought SAR Codse, which had the dru.still early stages. I think Shire paid 4170 million? Not sure. Ora Inc was doing early SAR Code work. but then there is a LAWSUIT between Shire and Ora...from late last Fall:
"LEXINGTON & ANDOVER, Mass.--(BUSINESS WIRE)--Ora and SARcode have resolved litigation concerning Ora's intellectual property and the parties have entered into a settlement agreement. Ora has granted SARcode and its affiliates a non-exclusive worldwide license to Ora's technology for use with Lifitegrast. Ora and SARcode's parent company, Shire, look forward to exploring opportunities that may arise to work together in the future.
SARcode Biosciences Inc. is a wholly-owned subsidiary of Shire."
Are you a short? Silly. you allude to some mystery "VP" selling. How about facts. One minor office sold TEN shares last November. That is all. Is that a big deal to you? the TRUE insider is Bresky, he owns over 900,000 SEB, or about 77%. no one is manipulating. NO insiders are cashing out. SEB just had a great run up.probably too far becaiuse it is thin.....and sellers come in to take profit.and SEB is again too thin...so it over does it down. Seller is probably worried Pork will be soft this Q.pork is down pretty hard a fact. However, CORN prices are also way down....so cost to feed pigs down. I think market overdoing it. I am bidding today at 3800 level. What no one sees is that the BIG surprise may come in Seaboard MArine division. SEB has about 30 BIG ocean going ships, that go 28 feet one ONE gallon of fuel. Oil goes from $100 to $50. KNOW HOW MUCH MONEY SEB will make on that drop?It will make up pork softness. Drop in oil also helps the D.R. oil electric generating barge. No insider selling. No manipulation. No saelling for taxes. I am nibbling at these levels.
I'm not sure which is the biggest news item in RGRX...the one that the Koreans pulled off a lot more $ financing that I believed they could....or the pure, cold, hard fact that NITE (and one or two other market makers) have all but abandoned their short and press down scam in RGRX. for at LEASt three to fours years, NITE was in 100% control of RGRX. We saw it. We checked FINRA daily shorting figures........but we get "blown off" that we are just silly, stupid, paranoid idiot retail penny biotech fools. WELL? look what happens! Miracles happen and pretty much ALL market makers....ESPECIALLY the NITE dirt bags.....have all but halted shorting RGRX, and they let it go as an HONEST market does.....up with buyers, down a bit with sellers. No more short & press down scam. It is really some of the most refreshing news I have seen in RGRX for many years. And it also proves that the supposed insane paranoid retail biotech investors.......had a POINT all along! And we were right. I am 100% sure that RGRX would not have gotten into such HORRIBLE financial condition..with stock down to 5 cents a share......and thus FORCED into horrible PIPE deals....had NITE not been scamming, shorting and pressing RGRX into oblivion...........and they were (are) naked short all the way and never reported to SEC. (which is legal, sadly, for any MM)
Bo.....Cool it! It is you whp are off. You say:
I QUOTE RGRX for trial dates! i don't make it up! Too many folks here say the trial(s) is staritng almost now or they say the patent news is "this week or next"... All I do is go to what RGRX says! They state that the US trial(s) are not till Q4....and we ALL know nothing goes on time. G Tree said the KOREA trial will not happen untio the second half 2015. Lee's is still waiting for gov't baloney paperwork approval...they had HOPED by end of June quarter. And then this patent stuff? The appeal could easily take months to review.
It is the CHINA trial I am most interested in. it will be teh first to come. Lee's has a FAR better track record and reputation, than G Tree or RGRX mgmt.... So if Lee's trial is good, it will carry weight..
Now, I will also make another prediction...that if Lee's dry eye trial starts June/July.....that RGRX & G Tree will hold off final trial design for both the EYe Nk and severe dry eye trials (phse 2 & 3) until they see the data from China,,which may aid in the design here & give a leg up on endpoints. This could push teh USA trials further back...If the Lee's trial goes well, RGRX is going up well befoer US trial anyways. That why I focus on Lee's for now. And bo...I have into six figures of shares here.... I have a lot......and I have two other much larger and higher octane $ swing stocks that are taking much of my time and worry. both have done extremely well over the last 6-8 months.
There is no trial starting i quickly. The Korea trial is not until 2nd half. the China trial perhaps by end of June quarter....but Chinese gov't always slow, maybe longer. the US trials not until 4th Q. So you have a wait. I do not expect any thing from patent stuff for a couple months. USPO takes their sweet #$%$ time, always!
Warrants are a real risk.Unless RGRX mgmt extends tehe life of them darned soon. They expire om May 21. Exercise price on warrant os 55 cents. warrants traded 4 cents. So to break even on that trade....in the next 43 days...RGRX has to be over 60 cents a share.. not my kind of gamble. if I played those kind of games, I would short the warrant and buy RGRX.one to one. If they exipre in 43 days worthless, you lower your RGRX cost by 4 cents. if RGRX zooms, you lower cost basis to 24 cents a share and make all that money from 24 to 60 vents (a 36 cent profiit on 24 cents)...but you make no money above 60 cents.
over the past 20 years RGRX mgmt has screwed up many a two car funeral. But even a broken clock is right twice a day. I am hopeful that FINALLY...this time.just ONE time....RGRX will get the trial design right. For the severe dry eye and the all important Eye Nk Phase 3 Orphan trial.
KISS."Keep It Simple Stupid"....should be the guiding design prinncipal. YOU GET THAT FINKEL? Why on earth did you go for all these varioous "sub sections" of the cornea for teh first Phase 2?.... because I have looked at several OTHER ORA INC trials and NONE OF THEM DID WHAT YOU DID. so why do you do it? Almost every triial...screwed...
I am praying that this time TB 4 will be designed correctly.
The test is carried out throughout the study till end of treatment Day 29. However, the primary outcome measure itself is determined on Day 29. Worst eye: In the case that both eyes were eligible for analysis, the worst eye was chosen as the eye with the greater increase of inferior corneal staining from Visit 1 to Visit 2. If both eyes were equal, the eye with greater ocular discomfort at Visit 2 was chosen as the worst eye. If both eyes had were equal at Visit 2, then the right eye was chosen as the worst eye.
and it goes on and n. RGRX is is own worst enemy.every trial:
"...Worst eye: In the case that both eyes were eligible for analysis, the worst eye was chosen as the eye with the greater increase of inferior corneal staining from Visit 1 to Visit 2. If both eyes were equal, the eye with greater ocular discomfort at Visit 2 was chosen as the worst eye. If both eyes were equal at Visit 2, then the right eye was chosen as the worst eye.
Ocular Discomfort in the Worst Eye in the Controlled Adverse Environment(CAE) Model, Which is a Regulated Environmental Setting Aimed at Exacerbating the Signs and Symptoms of Dry Eye. [ Time Frame: Day 29 (end of treatment) ] [ Designated as safety issue: No ]Dry eye causes ocular discomfort, which is measured using a validated 4-point ORA Scale from the start of the dosing till the end of treatment (Day 29). 0 = no discomfort to 4 = constant discomfort. If the measurement is lower, then improvement of ocular discomfort can be inferred.
to be continud....
If I can post all of it, here is RGRX trial design for Phase 2 by Ora. It was designed to be so hard to ever "pass". Only RGRX....
Primary Outcome Measures:
• Corneal Staining (Inferior Region) in the Worst Eye in the Controlled Adverse Environment (CAE) Model, Which is a Regulated Environmental Setting Aimed at Exacerbating the Signs and Symptoms of Dry Eye [ Time Frame: Day 29 (end of treatment) ] [ Designated as safety issue: No ]This is a test that uses orange dye (fluorescein) and a blue light to detect ocular surface defects associated with dry eye. If the test result is normal, the dye remains in the tear film on the surface of the eye and does not adhere to the eye itself. The test is carried out throughout the study till end of treatment Day 29. However, the primary outcome measure itself is determined on Day 29. The scale used to determine the difference in corneal fluorescein staining between RGN-259 and placebo is the ORA scale: 0= no staining (no detectable ocular defect)to 4= confluent staining( severe ocular defect).
to be continued....
If you look atr Ora Inc webpage you will see they just finishd sign up (ahead of schedule) of 160 pts for a dry eye trial. Company doing is called Herantis. I checked clinicaltrials to view the trial design. And, as usual, I shook my head in disgust at RGRX How is it so possible that they screw up every single trial, or trial design.in teh last 20 years. The RGRX phse 2 reads like it flopped because RGRX only chose two subsections of cornea to measure. It failed. But two other subsections did get statistical. But? By trial design & FDA, TB 4 flopped. So I read WHAT DID ORA do with this hearts company Dry Eye? It is so simple it is painful to see:
"Primary Outcome Measures:
Corneal Fluorescein Staining [ Time Frame: Day 29 ] [ Designated as safety issue: No ]
Symptom Score [ Time Frame: Day 22 to 28 ] [ Designated as safety issue: No ]"
SEE? The FDA approvd such a simple and VERY wide open end trial. Even 'designated safety issue was a "no".
NOW? Wait till I post nexyt the Primary Outcome that RGRX chose to do. What dopes.
I don't see any mention of the Korean trial lately.. But G Tree did a surprise good job at raising dough. And it was a pump and dump in a way. G tree got pumped from 3 won to almost 6 won..then G Tree sold a convertible bond. Ask yourself, is it better to sell aconvert with share price at 3 or almost 6?
What G Tree does after that is probably more hype and rumor. Because if anyone smart in Korea looked at the market cap they pay for G Tree in korea.and they own only a slice of TB 4 and area.....compared to the market cap of RGRX.and RGRX owns the whole cow...it is silly to buy Gtree...buy the cow (rgrx) for far less. So it indicates to me G Tree is probably in full pumping hype mode in Korea. If Korea was open to traders, a hedge fund would jump at shorting G Tree and long RGRX.
Can you show me where Gtree is starting their trial in Korea soon? I don't see it. I think possible they drop that idea and focus all effort on USA and use those trials for possible Korea approval submission. BTW? You will be LUCKY to see US trial start befpre end of year. You state it is.."GETTING READY TO START". No. Even RGRX states not till late this year.
To back up what I said about JBS listing on NYSE and the HUGE benefit of new institutional money that could (would) buy a JBS NYSE ADR.....I checked the JBSAY (Pink Sheets) institutional ownership filings with the SEC....for all USA managers with over $100 million of assets. Astoundingly......even though JBS is the largest protein company in the world, with over $43 BILLION in revenues...with over 300,000 employees and over 80% of all revenues in US Dollars......there are only TWO....yes, TWO investment firms that own the JBSAY ADR pink sheets. One owns 75,000 and the other owns 43,000. It's amazing to think..I own over 10,000 shares JBSAY...and I alone would thus qualify as the THIRD largest institutional holder. of JBSAY... in the WHOLE USA! And I am just small potatoes RETAIL!
Yeah, I sucked wind for a while here. Issue was/is that the Real went from 2.50 to 3.30. But as the Real tanked, the ADR in US Dollars allowed meyoi get more shares per purchase in USD. I kept buying. now the Real has gone 3.30 to about 3.15, and the dollar may weaken a bit further after Fridays employment figs. In meantime, JBS has said no new big M&A, and they focus on growing what they have and cutting down debt. I also hope they hedged some at Real 3.30? JBS shoudl buy back as much of the expensive Brazilian debt as they can, and re issue that deby in lower coupon USA. But what JBS should REALLY do is this. They are about the largest pure food/protein company in world. Buit few know -and even FEWER buy it in o/c ADR's. Similar huge Brazilian company, Vale, did smart move. They got their ADR's listed on NYSE, which instantly gave blessing for all huge funds to buy it. But JBSAY trades in "pink sheets", and big managers avoid that. JBS has to list the ADR's on NYSE, which opens up a WORLD $$$$ of new investors and money. The issue is, though..that to list on NYSE as an ADR, all your financials have to be of GAAP standards. JBSAY is not GAAP accounting right now. It is a reasonwhy no big funds will own JBS. Cut debt, grow organically...get JBSAY into GAAP international acounting standsrds and THEN list on NYSE....and then hope Real strengthens..and JBSAY will zoom. No one owns it in USA, and the story is great longer term. Big funds woudl have no choice but to own some, if listed on NYSE.
I'm not sure if the word "SEB in play" is right. Because there is no way SEB can be "in play' to wall Street unles the Bresky family wishes it so. They own 77.5%. It is impossible to put SEB in play unless they wish it. All teh Bresky stock is in a coupel of trusts. The family is getting extended with all kinds of other kids, grandkids.etc....Bresky is 61. I don't see he has any children coming into SEB, as he did with his father. There's a time to sell sometime. The Bresky Truats with 77.5% of SEB have ALL THEIR EGGS in ONE basket. And SEB isn't paying a divined now. So the Bresky family has close to $4 billion totally stranded and not diversified. The world is a crazy place - mideast wars?. I would want some safety & diversity in assets, for all Bresky family members part of the trust. But for Bresky to sell, It has to be a very premium price and it probably has to be someone who won't slash and burn costs & people, from what a few generations of the family built up. That is why I am not so sure about selling to a China company. The ideal buyer is Berkshire Hathaway. Bresky family get's a good price and Buffet let's Bresky continui to run and grow SEB as he sees fit. Buffet has no interest in running SEB, and Bresky has a superb 20 year record. He even beats Berkshire stock returns I think! I do not think funds are buying that much up here, but probably peeling some off. SEB from $2400 to $4200 in 8 months??? SEB trades now 9-10 times EBIDTA. Average for SEB is closer to trade 7-8 times EBIDTA. SEB is fair value here, IF there is NO deal. if there ever IS a deal, I expect 14-15 times EBIDTA, justified because SEB has ZERO LT debt and $525 million cash. That means at least $6,500 a share. Buyer is still here, very stealthy. As long as he is, I hold. Hope for a deal!
The Korean mkt is closed to outside folks like us. So probably easier to push G Tree with rumors. I highly doubt that G Tree has any info that., 'they know already" in regards to the fight on the Dry eye specific patent. the USPO is very transparent and they post publicly every decision or question they have..all dated. My guess is you have another month or two for a reply from USPO examiner. If you read the very long RGRX lawyer appeal, it is, detailed and cites many, many court references from earlier relevant USPO decisions..which the examiner will probably want to study himself. It is a very laborious process. What we hope is that RGRX lawyers wear him down with as many facts as they can. Clearly the examinier sees that RGRX is NOT going away quietly. So my guess is he gives in... eventually, as the USPO has done often before.after a 7-9 year RGRX lawyer fight in their face. RGRX lawyers will appeal if need be, I think, above this examiner, Roy T. And he does not want to look bad to his superiors he he refuses to grant patent on shaky issues he holds. I think he'll eventually just want it to "go away" and grant it, with some minor changes by RGRX, to make himself look smart. Save face.
I missed i. Thanks for pointing to it. SEB would be a fit. SEB has a 70,000 acre sugar plantation....it has a big grain trading division. Of course they'd love SEB pork divison, which is no#2 or 3 in USA (China needs pork). Not sure what they'd do with Seaboard Marine or the DR electric power barge.
I wonder if Bresky would sell the long family business to the Chinese Gov't? I don't know. I think Bresky must be loyal to his employees - who made him rich. So I hesitate to think Bresky would sell out to anyone who would fire, strip and downsize long time employees in name of cost cutting for profit. That could have been a problem if JBS Brazil was interested in SEB (another great fit). JBS would consolidate and layoff. MAybe the Chinese would let Bresky run? Who knows. Warren Buffet is also a possible buyer. SEB has a whoel basket of interesting assets that coudl not easily be replicated or replaced. Buffet looks for that.
I track almost every tick and trade during the day...for last 6 months. Someone is buying, really carefully, deliberately, and steady.almost every day and often on the close print and after hours. I would assume that if someone were to buy out SEB for a BIG price, they would want go own as much SEB as they could before hand. 5% of SEB is about 60,000 shares. Damn hard to buy 60,000 SEB. I figure in Q4, outside of institutional bought/sold..someone got 20,000 we don't know who. I figure they also took about 12,000 in Q1. I am holding a good sized position, for a deal. the buyer is here, stealthy. Any deal for SEB would have to be about $6,500. SEB has NO long term debt and sits on $525 million cash! An amazing balance sheet & asset base. A totally unique company. And oil collpase just made Seaboard MArine VERY profitable, where it lost about $20 million a year in last handful years each. SEB has 35 ships. They go 28 feet on ONE gallon of fuel! Oil price collapse is a HUGE win for SEB no one sees.YET! And they can hedge it out nowa few years too! $$
Here are more sniipptes that RGRX used as examples in teh issued 2012 wound patent:
"FIG. 7 shows a graph demonstrating the migration of corneal epithelial cells at various concentrations of T.beta.4.
FIG. 8 shows a graph representing corneal re-epithelialization in rat corneas in the presence and absence of T.beta.4.
FIG. 9 shows a graph representing corneal re-epithelialization in the presence and absence of various concentrations of T.beta.4. "
RGRX clearly showed examples of TB 4 healing wounds in the cornea. This issued patent was first applied for in 2005. After much fighting, the USPO granted it in 2012. But the majority of the patent does focus on skin related applications...as RGRX was looking then at pressure ulcers, venous ulcers and EB application...but eye issues are discussed. It may be a stretch, but the patent is granted TB 4 in wounds......RGRX shows examples of eyes being treated. Dry Eye causes a WOUND to the ocular surface. RGRX may be able to try and argue that this patent then covers eye wounds. but obviously, having the best IP is the best protection for your assets, TB 4. So RGRX filed more specific eye patents. A year or so ago, RGRX was granted a US PAtent for TB 4 relating to GLAUCOMA, as a DISEASE..not a "wound". RGRX also filed an almost exact similar worded application, except for Dry Eye specifically. It is true that RGRX is having some issues getting that patent to clear. but RGRX and thier lawyers are fighting back really hard. And they keep appealing. I think, AS IN SO MANY OTHER 7-9 YEAR USPO FIGHTS..that the USPO finally caves in after RGRX tweeks it to satisfy the USPO examiner, while giiving him (his name is Roy T) something to "save face". I get the sense that RGRX will take it to the abslolute limit and appeal to others- over Roy T's head - and they are fighting like heck. I think eventually the USPO gives in.before the US trials start. In meantime, if need be....RGRX may argue coverage under the granted WOUND patent.